ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2026
Spironolactone or Finerenone for Cardiovascular and Kidney Protection in Patients with Moderate CKD?
Panagiotis I Georgianos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.